GHRS
#2102
GH Research PLC - Ordinary Shares
27.3 6 USD
+0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.41%
Variazione Mensile
-2.88%
Variazione di 6 mesi
+77.09%
Variazione Annuale
+93.22%
Chiusura Precedente
26.9 8
Open
27.3 6
Minimo
27.3 6
Massimo
27.3 6
Volume
25
Financials
- Market Capitalization 1.7 B
- Employee 73
- Founded 2018
- CEO Theis Terwey
- Website www.ghres.com
- Headquarter Ireland
- FIGI N/A
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2070 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.69 USD | -0.31% | -5.16% | +19.83% | -7.51% | 1.78 B USD | ||
| 2075 |  SEPN Septerna, Inc. - Common Stock | 37.68 USD | -1.23% | -8.28% | +9.38% | +71.19% | 1.76 B USD | ||
| 2107 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.72 USD | -3.54% | -2.10% | -7.90% | +71.37% | 1.69 B USD | ||
| 2117 |  NVAX Novavax, Inc. - Common Stock | 10.12 USD | +8.00% | +8.47% | +37.50% | +34.57% | 1.67 B USD |